MedPath

Impact of Hip Flexors Isokinetic Strengthening on Gait Capacities in Subacute Stroke Patients

Not Applicable
Withdrawn
Conditions
Gait
Stroke
Hemiplegia
Interventions
Procedure: Conventional rehabilitation
Procedure: Isokinetic hip flexors strengthening
Registration Number
NCT02917850
Lead Sponsor
University Hospital, Lille
Brief Summary

Post-stroke patients often present with gait disorders due to several physical impairments. Hip flexor deficit is one of the more prevalent trouble and is associated with gait capacities. This study aims at evaluating the impact of an isokinetic hip flexors strengthening rehabilitation program in the subacute phase after stroke. Patients will be randomized to an intervention group (isokinetic rehabilitation) or a control group (conventional rehabilitation) and assessed at the end of the rehabilitation program, at 3 and at 6 months.

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Patients suffering from a first ever stroke
  • At the subacute phase
  • Able to walk at least 10m with or without assistive devices
  • Hip flexors strength on the paretic side > 2/5 (MRC)
Exclusion Criteria
  • Uncontrolled epilepsy
  • Contraindications to physical activity (severe arterial hypertension, aortic valvulopathy, severe PAD...)
  • History of muscular or joint disorders on the paretic hip
  • Subject unable to deliver an informed written consent (due to aphasia, cognitive or psychiatric disorders...)
  • Protected persons
  • Pregnancy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ControlConventional rehabilitationPatients who benefit from a conventional rehabilitation program
IsokineticIsokinetic hip flexors strengtheningPatients who benefit from the hip flexors isokinetic strengthening rehabilitation program
IsokineticConventional rehabilitationPatients who benefit from the hip flexors isokinetic strengthening rehabilitation program
Primary Outcome Measures
NameTimeMethod
Max gait speed (m/s)6 weeks

Gait speed will be assessed in the 10m walk test

Secondary Outcome Measures
NameTimeMethod
Hip flexors strength6weeks; 3 and 6 months

Hip flexors strength will be evaluated using an isokinetic dynamometer (concentric, 30°/s) and motor testing (medical research council)

Gait endurance6 weeks; 3 and 6 months

Gait endurance will be assessed using the 6MWT

Gait capacities6 weeks; 3 and 6 months

Functional ambulation categories (FAC)

Rate of perceived exhaustion during gait6 weeks; 3 and 6 months

Borg scale

Max gait speed (m/s)3 and 6 months

Gait speed will be assessed in the 10m walk test

Balance and postural control6 weeks; 3 and 6 months

Timed-up and go test

© Copyright 2025. All Rights Reserved by MedPath